119th Congress
H.R. 830
SAFE Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Chris Pappas(D-NH)
- Introduced
- Jan 31, 2025
- Policy area
- Crime and Law Enforcement
- Committees
- House Committee on Energy and Commerce; House Committee on the Judiciary
- Official text
- Introduced in House · Congress.gov page
Cosponsors (17)
Original cosponsors (2)
- Dan Newhouse (R-WA)
- Maria Elvira Salazar (R-FL)
Added later (15)
- Angie Craig (D-MN) · Feb 4, 2025
- Chrissy Houlahan (D-PA) · Feb 4, 2025
- Jason Crow (D-CO) · Feb 4, 2025
- Jennifer L. McClellan (D-VA) · Feb 4, 2025
- Johnny Olszewski, Jr. (D-MD) · Feb 4, 2025
- Nikki Budzinski (D-IL) · Feb 4, 2025
- Scott H. Peters (D-CA) · Feb 4, 2025
- Shomari Figures (D-AL) · Feb 4, 2025
- C001078 · Feb 5, 2025
- Gilbert Ray Cisneros, Jr. (D-CA) · Feb 6, 2025
- Sharice Davids (D-KS) · Feb 7, 2025
- Raul Ruiz (D-CA) · Feb 24, 2025
- Ami Bera (D-CA) · Feb 25, 2025
- Brian K. Fitzpatrick (R-PA) · Mar 10, 2025
- Seth Magaziner (D-RI) · Nov 17, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Save Americans from the Fentanyl Emergency Act or the SAFE Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025.
It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.
The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including
• permitting a single registration for related research sites in certain circumstances,
• waiving the requirement for a new inspection in certain situations, and
• allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 31, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Jan 31, 2025
Introduced in House